We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Andrew Lotery

Andrew J Lotery MD, FRCOphth

Chair, Hydroxychloroquine and chloroquine guidelines committee, Royal College of Ophthalmologists, Professor of Ophthalmology, University Of Southampton, UK

Andrew’s clinical specialty is medical retina with major research interests in age-related macular degeneration, central serous chorio-retinopathy and inherited retinal diseases. Currently he is Chair of the Scientific Committee of the Royal College of Ophthalmologists. He has been awarded the Nettleship Award for Research by the Royal College of Ophthalmologists and was listed in the Times as one of the United Kingdom’s top 100 doctors. He was editor in chief of Eye for 10 years. He and his team have performed over 75 clinical trials and published over 200 papers in high impact journals including Nature Genetics, Nature Communications, the Lancet and the New England Journal of Medicine. He has served two times as an NIHR Senior Investigator and raised grant funding totalling over £15 million.

Recent Contributions to PracticeUpdate:

  1. Screening and Management of Hydroxychloroquine Retinopathy